EXTON, Pa., July 29 Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its fourth quarter and fiscal year ended June 30, 2009 at 7:30 A.M. Eastern Time on Thursday, August 20, 2009.
Advertisement
Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Thursday, August 20, 2009 at 9:00 A.M. Eastern Time.
Advertisement
To participate in the teleconference call, dial 1-612-234-9959. The teleconference call will also be available for replay starting Thursday, August 20, 2009 at 11:00 A.M. Eastern Time through Thursday, August 27, 2009 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 109060.
Individuals interested in listening to the teleconference may also do so over the Internet at www.kenseynash.com. To listen to the live teleconference call, please go to the www.kenseynash.com website and choose the Investor Relations page. Please allow 15 minutes prior to the start of the call to register and download and/or install any necessary software. A replay of the teleconference will be archived on the www.kenseynash.com website and may be accessed following the teleconference.
About Kensey Nash Corporation. Kensey Nash Corporation is a leader in developing, manufacturing and processing resorbable biomaterial products, incorporating its proprietary collagen and synthetic polymer technology. This expertise is used to develop and commercialize its products through strategic partners. The company has an extensive range of products, which are sold in multiple medical markets, including, the cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets. The company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
SOURCE Kensey Nash Corporation
